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E lectroneurography (ENoG) and clinical staging are
currently the methods of choice to indicate prognosis in
Bell’s palsy, although ENoG is an electrophysiological
test not universally available. Aim: Identify other options
of prognostic evaluation based upon clinical aspects and
minimal electrical stimulation test allowing prognostic
measurement in almost any circumstances. Study
design: historic cohort. Material and Method: Chart
review of 1,521 cases of IPFP, analyzing the following
clinical aspects: gender, age, paralyzed side, installation
mode, previous symptoms, associated symptoms and
minimal electrical stimulation test (Hilger test) and its
statistical correlation to facial palsy evolution after 6
months. Results: Data indicated that patients above 60
years old had worse prognosis in comparison with
patients under 30 years old. A progressive mode of
paralysis installation, absence of previous symptoms,
concomitant vertigo and response superior to 3.5 mA at
minimum electrical stimulation test were also related to
worse prognosis. On the other hand, the absence of
concomitant symptoms, diminished tearing and sudden
onset were related to better prognosis. Conclusion:
Clinical factors and Hilger’s test can accurately indicate
the prognosis in cases of Bell’s palsy when ENoG is not
available.
Key words: Bell’s palsy, prognosis,
clinical data, Hilger test.
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INTRODUCTION
Bell’s palsy or idiopathic peripheral facial palsy is a
relatively frequent disease all over the world. It affects all
age ranges, without gender preference, with complete
recovery in most cases. However, a considerable portion of
the patients maintains permanent functional deficit causing
psychological, social and professional abnormalities.
ENT examination, clinical history and otoneurological
assessment should be carefully made and followed by
complementary exams such as audiological assessment,
imaging exams and biochemical analyses. These measures
allow precise etiological diagnosis, leading to specific
therapeutic indication. Normally, clinical information is
directed to the attempt to define an etiological diagnosis,
and the prognosis of palsy is defined by electrical tests,
especially electroneuronography (ENoG). Even though it is
a very important method to indicate the prognosis of facial
palsy, EnoG is not available in all centers, especially in
emergency centers. Conversely, basic clinical data are
routinely obtained under any circumstances. Thus, it would
be important to know the value of these clinical data in
relation to disease prognosis. Factors such as gender, age,
side of palsy, onset, previous symptoms, and associated
symptoms most probably influence the progression of the
cases. In addition, the test of minimum electrical stimulation
(Hilger test) is a simple test to conduct and available in
most centers of Otorhinolaryngology.
The present study aimed at statistically correlating
clinical data and the results of Hilger test with level of final
recovery of facial function in cases of Bell’s palsy, trying to
identify which factors would have more prognostic value.
MATERIAL AND METHOD
Cohort retrospective study analyzing 2,660 patients
with Bell’s palsy followed up in the ambulatory of Otology,
between 1986 and 2001. Out of the total, 1,521 patients
formed the sample, complying with the following inclusion
criteria: clinical and ENT assessment with classification of
palsy according to House-Brackman classification1 in the
first visit and after 6 months of progression; electrical
stimulation test (Hilger)2 conducted in the first assessment,
patients that were not submitted to clinical treatment with
corticoids for clinical reasons (diabetes, decompensated
blood hypertension, glaucoma, etc) or simply no
compliance to medication.
The cases with poor initial progression that were
referred to surgery were maintained in the assessment and
their data were considered as indicative of poor prognosis.
The statistical analysis was performed with chi-square
test, with level of significance of 5%. If the observed value
(OV) was greater or equal to the critical value (CV), there
was significant correlation.
RESULTS
Out of 1,521 patients, 58.8% (894) were female
patients and 41.2% (627) were male patients. Gender did
not present any statistical difference concerning final grade
of palsy (OV: 0.02, CV: 3.84).
We detected higher incidence of palsy between
ages 11 and 31 years, and the smallest incidence was
detected in the extreme age ranges: between 0 and 10
years and over the age of 61 years (Table 1). As to
progression, we observed that most of the patients (69%)
progressed to final staging as grade I. The progression
was proportional in all age ranges, as observed in Graph
1. However, there was statistically significant difference
between final grade of facial palsy between the patients
aged 0 to 10 years and patients with ages over 61 years,
with higher incidence of final grade I in the first group
and higher incidences of grades II-VI in the second group
(OV:16.4 and CV 12.59). The other age ranges did not
present significant difference concerning final grade of
palsy.
As to affected side, 52.1% (792) of the patients
presented right facial palsy and 47.9% (729) had left palsy,
Table 1. Correlation between final grade of facial palsy and age range.
Age range Final grade I % Final grade II-VI % Total %
0-10 101 9,6 24 5,1 125 8,2
11-20 201 19,2 81 17,3 282 18,6
21-30 231 22,1 110 23,5 341 22,5
31-40 164 15,7 84 17,9 248 16,4
41-50 128 12,2 60 12,8 188 12,4
51-60 120 11,5 48 10,2 168 11,1
61- 102 9,7 62 13,2 164 10,8
Total 1047 100 469 100 1516
Chi-square test: observed value of 16.4 and critical value of 12.59 - there was positive correlation. The age range below 10 years presented
higher incidence of final grade I whereas the age range over 61 years presented higher incidence of final grade II-VI.
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and there was no correlation between the palsy side and
final staging (OV 0.10 and CV 3.84).
As to data related to previous symptoms, the incidence
of patients without previous symptoms was 26.2%; earache
complaint was found in 23.5%; nervousness (stress) in 19%,
facial paresthesia in 15.8%. headache in 8.9%, aphthae in
4.6%, and other symptoms in 1.9%. There was a significant
correlation between presence and absence of previous
symptoms and final grade of palsy, and the absence of
symptoms was statistically related with higher incidence of
final grade II-VI (poor progression) (OV 18.09% and CV
12.59%). Individual analysis of previous symptoms did not
present correlation with final grade of palsy.
As to concomitant symptoms, 21.5% of the patients
had no symptoms, and there was hyper lachrymation in
23.8%, dysgeosia in 19.5%, hypo lachrymation in 10.8%,
tinnitus in 9.4%, vertigo in 8.6% and other symptoms in
6.4%. There was significant correlation (OV 101.13, CV 14.07)
between symptoms and final grade of palsy, and the absence
of concomitant symptoms and hyper lachrymation were
related to final grade I, whereas vertigo was more associated
with final grade II-VI. Dysgeosia, hypo lachrymation and
hearing loss did not present any correlation with progression.
Hilger test was performed in 1,292 patients. The test
demonstrated a significant correlation with prognosis of the
disease, and the patients with unexcitability presented higher
incidence of final grade II-VI palsy. Among the cases that
presented complete resolution, only 1.5% had compatible
result with poor prognosis (different thresholds of excitability
over 3.5mA or absence of excitability), whereas among
patients with poor progression, 32% presented results that
were considered to be unfavorable to the test, with statistically
significant difference (OV 260.94, CV 3.84).
The sudden onset of palsy presented higher incidence
(72.5%) than progressive onset (27.5%). Out of all patients
that progressed to final grade I, 86.2% presented sudden
onset facial palsy, whereas in the group of patients with
final evolution to grades II-VI, this percentage was only 42.2%
(Table 3). Thus, there was statistically significant difference
in relation to type of palsy and prognosis, and progressive
onset was related to unfavorable prognosis (OV:313.3, CV:
3.84).
DISCUSSION
The present study revealed the incidence of
peripheral facial palsy to be higher in women than in men,
in a proportion of 1.44:1, without any statistically significant
difference. In the literature, however, data are controversial.
Table 2. Relation between Hilger test and final grade of facial palsy.
Hilger Final grade I % Final grade II-VI % Total %
Excitable 873 98,5 276 68,0 1149 88,9
Unexcitable 13 1,5 130 32,0 143 11,1
Total 886 100 406 100 1292
Chi-square test: observed value or 206.94, critical value of 3.84. There was significant correlation between Hilger test and the prognosis. The
group with unexcitable Hilger presented higher incidence of unfavorable grade.
Table 3. Correlation between final grade of facial palsy and type of onset.
Onset Final grade I % Final grade II-VI % Total %
Acute 901 86,2 201 42,2 1102 72,5
Progressive 144 13,8 275 57,8 419 27,5
Total 1045 100 476 100 1521 100
Chi-square test: observed value of 313.3, critical value of 3.84. There was significant correlation between onset of the disease and prognosis.
Patients with sudden onset presented favorable diagnosis, whereas the others presented progressive onset and unfavorable prognosis.
Graph 1. Correlation between age range and final grade of facial
palsy. We could observe that the curves of favorable prognosis
were parallel, with peak of incidence in the age range 21 to 30
years.
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Adour et al 3, assessed 1,048 patients and did not observe
any difference among genders, but the frequency was twice
higher in female patients aged 10 to 19 years, and 1.5 times
higher in male patients aged over 40 years. Devriese et al.4
did not find predominance between genders in their study
with 1,293 cases. In the present study, there was no
association between gender and grade of functional recovery,
suggesting that this factor does not influence the prognosis
of the disease.
As to age, we observed that the highest number of
Bell’s palsy cases occurred in the age range 21 to 30 years,
corresponding to 22.5% of the total of patients. The lowest
incidence was defined in extreme ranges (0 and 10 years
and over 61 years). The prognosis proved to be more
favorable in the younger age ranges, especially below 10
years, whereas patients over 61 years presented higher
incidence of final grades II-VI. Katusic et al.5 observed higher
rate of incomplete recovery in the age range above 55 years
and Smith6, in 1988, in patients over the age of 60 years.
Danielidis 7 related age as an important factor to determine
the prognosis of the patient.
In our study, there was no predominance related to
the affected side, and we did not observe any correlation
between paralyzed side and recovery of palsy. We found
only 1 case of bilateral facial palsy, which corresponded to
0.08% of the total, which is in accordance with the incidence
below 1% reported by Gregg8, Leibowitz9, Adour3 and
Yanagihara10.
Considering the most predominant previous
symptoms, otalgia (23.5%), stress (19.0%), paresthesia
(15.8%), headache (8.9%) and aphtha (4.6%) were the most
frequent ones in our sample, whereas 26.2% did not present
any prodromic signs or symptoms. May11 found otalgia in
50% of the patients, paresthesia in 40% and viral prodrome
in 60%. Adour3 reported 20% viral prodrome, 10% headache
and 32% facial paresthesia in the study with 515 patients.
According to Fortes and Rego12 and Furuta13, insult to the
nerve could be resultant from the reactivation of the latent
nerve located in axons and nervous endings, triggering
inflammation and infection in adjacent cells after a trauma,
exposure to aggressive environmental factors or metabolic
and/or emotional affections. Riskalla14 reported that in most
of the idiopathic peripheral facial palsy cases, there was
presence of stress before the onset of the disease. In this
study, the patients without previous symptoms had higher
incidence of final grade II-IV palsy. Conversely, the presence
of previous paresthesia was correlated with good prognosis.
The other symptoms proved to be indifferent concerning
the progression.
As to concomitant symptoms to facial palsy, hyper
lachrymation was the most frequent complaint (23.8%),
followed by dysgeosia (19.5%) and hypo lachrymation
(10.8%). We observed that absence of symptoms and hypo
lachrymation were related with favorable prognosis, whereas
vertigo was associated with final grade II-VI. Adour3, however,
presented contrary results correlating unfavorable progression
with presence of dysgeosia and hypo lachrymation. May11
agreed that hypo lachrymation would be an important clinical
sign related with unfavorable prognosis. Other authors such
as Hauser et al.15, Katusic et al.5 and Smith et al.6 did not
identify statistically significant differences between prognosis
and incidence of concomitant signs and symptoms in cases
of idiopathic peripheral facial palsy. These statistical
differences concerning prognosis and symptoms can be in
part attributed to total number of studied patients and
adopted methodology. Samples over 1,000 patients obviously
present more consistent statistical data.
As to onset, we detected sudden onset in 72.5% of
the cases and progressive onset in 27.5%, in agreement with
Davidson16. Patients that progressed with final grade I
presented 86.2% of sudden onset, whereas 57.8% of the
patients that progressed unfavorably presented progressive
onset, with statistically significant difference. Thus, sudden
onset is indicative of better prognosis and progressive onset
indicates poor evolution.
As to Hilger test, cases that presented complete
resolution had 1.5% of compatible result with poor
prognosis (difference between excitability thresholds over
3.5mA or absence of excitability), whereas among other
patients with poor progression, 32% presented results that
were unfavorable, resulting in statistically significant
difference. Unfavorable results were considered those that
had difference of minimum excitability greater than 3.5mA,
as suggested by authors such as Campbell17 and Laumans
and Jongkees18. The prognostic value is reported as having
sensitivity between 85 and 95% by Jackson19, Lewis et
al.20 who reported that the test proved to be efficient,
economic and easy to handle, which is a method for
prognostic screening in cases of peripheral facial palsy,
which is in agreement with our results. Even though
without the specificity of EnoG, this test can, together
with other pieces of information, be used to estimate the
prognosis.
CONCLUSION
Data obtained from assessment of 1,521 patients with
Bell’s palsy in our service indicated that younger patients
(especially those below 20 years) presented better prognosis
compared to older patients (over 61 years); absence of
previous symptoms before onset of palsy was related to
poor prognosis; absence of concomitant symptoms and hypo
lachrymation during palsy were related with good prognosis,
whereas vertigo concomitant with palsy indicated
unfavorable prognosis; sudden onset of palsy was related
with good prognosis whereas progressive onset indicated
poor prognosis; favorable result of Hilger test was related
with good prognosis.
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